FDA Investigator Lauren M Lawrance
Lauren M Lawrance has conducted inspections on 155 sites in 3 countries as of 13 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
155
Last Inspection Date:
13 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Germany,
Switzerland
FDA Investigators that have inspected at least one site in common with Lauren M Lawrance:
Abby E Pelletier,
Alan R Condon,
Aldo J Quintana,
Alfred P Pistorio,
Alice C Silva,
Alissa E Berryman,
Allison A Rodriguez,
Almaris N Alonso,
Alois P Provost,
Althea A Williams,
Alysia M Salonia,
Amber G Wardwell,
Amy C Jordan,
Amy M Cramer,
Andre S Lamontagne,
Andrew M Barlow,
Andrew P Abban,
Anne E Carpenter,
Anthony P Costello,
Anthony W Thomas,
Ashley M Whitehurst,
Atricia L Irons,
Bradford L Swanson,
Bradley D Newsad,
Brenda P King,
Byungja E Marciante,
Carla C Cummins,
Carla C Tuite,
Christine L Williams,
Christopher A Demitrius,
Christopher K Vantwuyver,
Christopher M Elliott,
Courtney N Long,
Darin S Wiegers,
David J Feria,
David M Lamoureux,
David P Vanhouten,
Dawn M Braswell,
Diane M Biron,
Dominic R Frasca,
Donahue,
Donna J Clevenger,
Dorothy W Lee,
Douglas S Joslin,
Eduardo L Rodriguez,
Edward J Janik,
Elise L Mcdevitt,
Elizabeth B Griffin,
Emily J Schramm,
Eric C Schmitt,
Erich P Garger,
Erin P Conlin,
Frank J Koch,
Frank J Marciniak,
Frank K Fulford,
Gale E Ryan,
Gary J Hagan,
George T Allen, Jr,
Gerard D Difiore,
Guozhou Mo,
Hien Albright,
Intkhab H Wahla,
James H Tanner,
James P Finn,
Jamie S Mathews,
Janete F Guardia,
Janis S Gallagher,
Jason D Tenney,
Jay M Patria,
Jeffrey J Thibodeau,
Jeffrey S Buckser,
Jessica D Spellman,
Jessica I Newman,
John A Hamilton, III,
John A Hollings,
John A Sciacchitano,
John L Zaccone,
John P Shelton,
John R Carlson,
Jonathan B Lewis,
Jonathan G Matrisciano,
Joppie,
Joseph B Cascio,
Joseph Foley,
Joseph S Matrisciano,
Joyce A Kellett,
Joyce A Williams,
Justine M Corson,
Karen Mcnabb Noon,
Katarzyna Plona,
Kathleen A Sousa,
Kathleen E Mcafoose,
Kathleen M Curry,
Kent A Conforti,
Kristy B Yeaw,
Lauren M Mclaughlin,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Liz M Otero,
Lorayne A Mcguinness,
Louis Christy,
Lyndsay M Perryman,
Lynne M Dwyer,
Marcia M Laughrey,
Margaret E Walsh,
Mark E Farrell,
Martin J Guardia,
Mary Jeanet Mcgarry,
Maryam Tabatabaie,
Maura Rooney,
Mclaughlin,
Megan A Haggerty,
Michael E Antaya,
Michael G Mayfield,
Michael J Pasternak,
Michael P Sweeney,
Michelle M Noe Varga,
Morgan J Matthews,
Mutahar S Shamsi,
Nabil Nakhoul,
Nasser Yazdani, DVM, MPH,
Nicholas J Scire,
Nichole B Murphy,
Oganr,
Osama A Khatib,
Pamela L Lee,
Pamela L Ogonowski,
Paraluman S Leonin,
Paul P Geraci,
Philip H Lafleur,
Philip Kreiter,
Ramcharan S Khalsa,
Ramon E Martinez,
Rebecca A Coleman,
Remal,
Richard F Hapke,
Richard H Penta,
Richard L Friedman,
Richard L Licari,
Richard W Skodinski,
Robert D Ogan,
Robert E Teel,
Robert J Martin,
Robert O'brian,
Rory K Geyer,
Rupa Pradhan,
Sandra P White,
Sara M Onyango,
Sarah Forney,
Sean M Tessicini,
Seth A Mailhot,
Shawn M Bogdan,
Slater K Bartlett,
Stacey S Degarmo,
Stefan Kaszycki,
Stephen C Smith,
Steven M Ferrara,
Sunita Pandey,
Susan M Jackson,
Suwaskie S Smith,
Suzanne M Healy,
Tamara S Rosbury,
Teddy Tom,
Terry C Kimball,
Thomas Cote,
Thomas J Kelly,
Thomas J Murphy,
Thomas O Morgan,
Thomas Siebertz,
Thomas W Nerney,
Timothy M Glod,
Torrance J Slayton,
Troy R Petrillo,
Vantwuyverc,
Victoria Taylor,
Wendy A Johnecheck,
William K Dagley,
Zhichao Lin,
Zhong Y Wu
Lauren M Lawrance's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2012 | FDA 483 | Ameridose, LLC - Form 483, 2012-11-09 |
October, 2008 | FDA 483 | Blackstone Medical Inc. - Form 483, 2008-10-07 |
September, 2012 | FDA 483 | Brain Research, Inc. - Form 483, 2012-09-07 |
October, 2008 | FDA 483 Response | Blackstone Medical Inc. - Form 483R, 2008-10-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more